Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘13 |
|
|---|---|---|---|---|---|
| $42.2M | $45.1M | $2.89M | 88.6% |
|
|
| $42.1M | $112M | $69.8M | 726% |
|
|
| $41.4M | $56.7M | $15.3M | 470% |
|
|
179
Celldex Therapeutics
CLDX
$2.53B
| $40.9M | $73.3M | $32.4M | 93.9% |
|
| $40.8M | $210M | $170M | 334% |
|
|
| $40.4M | $168M | $128M | 14.3% |
|
|
| $40.2M | $143M | $103M | 92.1% |
|
|
| $39.6M | $39.7M | $85K | 16.9% |
|
|
| $39.5M | $71.8M | $32.3M | 298% |
|
|
| $39.1M | $82.2M | $43.1M | 86.6% |
|
|
186
Freeport-McMoran
FCX
$97.4B
| $39M | $1.16B | $1.13B | 105% |
|
| $38.3M | $66.9M | $28.6M | 284% |
|
|
| $37.4M | $45.8M | $8.36M | 58.5% |
|
|
| $37.4M | $208M | $171M | 60% |
|
|
| $37.3M | $184M | $147M | 142% |
|
|
| $37.3M | $51.4M | $14.1M | 294% |
|
|
| $36.6M | $258M | $221M | 164% |
|
|
| $36.5M | $113M | $76.4M | 64.4% |
|
|
| $36.4M | $119M | $82.8M | 111% |
|
|
| $36.3M | $86.8M | $50.5M | 655% |
|
|
| $36M | $417M | $381M | 72.3% |
|
|
| $35.4M | $138M | $102M | 392% |
|
|
| $35.2M | $109M | $74.1M | 2,755% |
|
|
| $35.2M | $113M | $77.9M | 91% |
|
|
| $35M | $108M | $73.3M | 145% |
|